Table 7.
First Author, Year [ref] | Experimental Design and Treatment | Results |
---|---|---|
Animal studies | ||
Lin, 2011 [61] | Acetic acid-induced FM-like pain model | Compared to vehicle group, genistein group: |
C57/BL6 mice (8–12-week-old) | ||
Treatments: vehicle treated with substance P (SP to induce current), genistein (30 µM), SP + genistein, SP + daidzein (30 µM) for 10 min on DRG neurons | ↓ SP-mediated inhibition of ASIC3-selective current and PTK activity of muscle dorsal root ganglion neuron | |
Jie, 2018 [68] | Glutamate-induced masseter muscle FM-like pain model |
Compared to control group, genistein groups: |
↓ mechanical hypernociception at high genistein dose | ||
Female Sprague-Dawley OVX rats | Partially reversed E2-potentiated glutamate-evoked hypernociception of masseter muscle | |
Treatments: no injections (control); E2 vehicle + genistein, E2 + genistein vehicle, and E2 + genistein (2–60 mg/kg) for 12 days. | ↓ pNR2B and pERK1/2 expression in hippocampus |
Abbreviation: ASIC3, acid-sensing ion channel 3; DRG, dorsal root ganglion; E2, 17β-estradiol; i.m., intramuscular; OVX, ovariectomized/ovariectomy; pERK1/2, phosphorylated mitogen-activated protein kinase; PTK, phosphotyrosine kinase; pNR2B, N-methyl-d-aspartate receptor of the NR2B subunit; SP, substance P; ↑ increase; ↓ decrease; ↔ no difference.